TY - JOUR
T1 - Heterogeneous clinical features in patients with pulmonary fibrosis showing histology of pleuroparenchymal fibroelastosis
AU - Yoshida, Yuji
AU - Nagata, Nobuhiko
AU - Tsuruta, Nobuko
AU - Kitasato, Yasuhiko
AU - Wakamatsu, Kentaro
AU - Yoshimi, Michihiro
AU - Ishii, Hiroshi
AU - Hirota, Takako
AU - Hamada, Naoki
AU - Fujita, Masaki
AU - Nabeshima, Kazuki
AU - Kiyomi, Fumiaki
AU - Watanabe, Kentaro
N1 - Funding Information:
This study was partially supported by the Practical Research Project for Rare Intractable Diseases from the Japan Agency for Medical Research and Development, AMED . This study was also partially supported by a grant from the Ministry of Health, Labour and Welfare of Japan awarded to the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases .
Publisher Copyright:
© 2015 The Japanese Respiratory Society.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Background: The histological pattern of pleuroparenchymal fibroelastosis (PPFE) is well defined, but its clinical features remain unclear. Methods: We retrospectively examined the predominantly involved lung-fields (based on abnormal opacities on computed tomography [CT] images), and the initial value and annual decline of respiratory function in patients with pulmonary fibrosis presenting with histologically confirmed PPFE. Results: Thirteen female and nine male subjects were included. Eleven interpreters independently analyzed 231 CT image series. One-third of the CT series (78/231) was interpreted as demonstrating equal involvement of the upper and lower lung fields, i.e., six out of 21 patients had equal involvement of the upper and lower lung fields, based on a majority decision of the interpreters. The residual volume/total lung capacity (RV/TLC) was increased and correlated inversely with forced vital capacity (FVC) at the initial measurement. FVC followed two patterns of decline over time: a gradual decline over a follow-up period of more than 6 years (-55 mL/year, R2=0.799), and a relatively rapid decline over a shorter period (-364 mL/year, R2=0.855) as determined by mixed-effect linear regression. Conclusions: The predominantly involved sites seen on CT images of PPFE were not limited to the upper lobes. In some cases, upper lung fields were predominantly involved, but in other cases, both upper and lower lung fields were equally involved. Two patterns of FVC decline exists: a rapid decline over a short period and a slow decline over a longer period, suggesting that the disease follows a heterogeneous clinical course.
AB - Background: The histological pattern of pleuroparenchymal fibroelastosis (PPFE) is well defined, but its clinical features remain unclear. Methods: We retrospectively examined the predominantly involved lung-fields (based on abnormal opacities on computed tomography [CT] images), and the initial value and annual decline of respiratory function in patients with pulmonary fibrosis presenting with histologically confirmed PPFE. Results: Thirteen female and nine male subjects were included. Eleven interpreters independently analyzed 231 CT image series. One-third of the CT series (78/231) was interpreted as demonstrating equal involvement of the upper and lower lung fields, i.e., six out of 21 patients had equal involvement of the upper and lower lung fields, based on a majority decision of the interpreters. The residual volume/total lung capacity (RV/TLC) was increased and correlated inversely with forced vital capacity (FVC) at the initial measurement. FVC followed two patterns of decline over time: a gradual decline over a follow-up period of more than 6 years (-55 mL/year, R2=0.799), and a relatively rapid decline over a shorter period (-364 mL/year, R2=0.855) as determined by mixed-effect linear regression. Conclusions: The predominantly involved sites seen on CT images of PPFE were not limited to the upper lobes. In some cases, upper lung fields were predominantly involved, but in other cases, both upper and lower lung fields were equally involved. Two patterns of FVC decline exists: a rapid decline over a short period and a slow decline over a longer period, suggesting that the disease follows a heterogeneous clinical course.
UR - http://www.scopus.com/inward/record.url?scp=84952020642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952020642&partnerID=8YFLogxK
U2 - 10.1016/j.resinv.2015.11.002
DO - 10.1016/j.resinv.2015.11.002
M3 - Article
C2 - 27108011
AN - SCOPUS:84952020642
SN - 2212-5345
VL - 54
SP - 162
EP - 169
JO - Respiratory Investigation
JF - Respiratory Investigation
IS - 3
ER -